The OncoProt platform offers to combine laser microdissection and mass spectrometry to study the proteome of all types of oncological cellular or tissue structures
Microdissection makes it possible to isolate a particular population of cells or a cellular region of interest using laser cutting, from specimens fixed in formalin and embedded in paraffin.
The proteins are then extracted after reversal of the binding, and are analyzed by mass spectrometry to identify and quantify them. By proteomic profiling, we can use all the deregulated proteins as an identity card for a pathology, which makes it possible to define reference profiles with diagnostic, prognostic value or response to treatments.
Thanks to dedicated bioinformatics and integrative biology tools and the intervention of the bioinformatician of our team, we can be of support in the biological interpretation of proteomics data and in the graphical representation of your results.
Company Details
- Founded
- -
- Address
- 146, Rue Leo Saignat, Uar Tbmcore Cnrs 3427 / Inserm Us 005 Université De Bordeaux - Bâtiment Bordeaux Biologie Santé,france
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Keywords
- Bordeaux.
- HQ
- Bordeaux, Nouvelle Aquitaine
Oncoprot Questions
Oncoprot's website is https://www.tbmcore.cnrs.fr/oncoprot/
Oncoprot's LinkedIn profile is https://fr.linkedin.com/company/oncoprot
Oncoprot's industry is
Research Services
Oncoprot's top competitors are
Beliver,
Bric-Bordeaux Institute Of Oncology,
Coave Therapeutics,
Pharmanetwork,
Dixi Medical,
Macquarie Group,
Sæptum,
Iresp - Institut Pour La Recherche En Santé Publique,
Knauer,
Tbmcore.
Oncoprot's categories are Research Services
Oncoprot's founding year is 2017
